Dietrich A. Stephan
CEO, Chairman and Founder NeuBase Therapeutics, Pittsburgh, PA USA

DOI:10.5912/jcb995


Abstract:

NeuBase is accelerating the genetic revolution by developing a new class of precision genetic medicines which can be designed to increase, decrease, or change gene function, as appropriate, to resolve genetic defects that drive disease.